ROCKVILLE, Md.--(BUSINESS WIRE)--Jan. 28, 2003--HealthExtras, Inc. (NASDAQ: HLEX), will release its fourth quarter and year-end 2002 earnings results on Tuesday, February 4, 2003 before the market opens.

The Company will hold a conference call on Tuesday, February 4, 2003 at 10:00 a.m. Eastern time. To participate, call 1-888-858-4066 or 1-973-935-2100 ten minutes prior to the scheduled start time and request to be connected to the HealthExtras conference call. The conference call will also be broadcast live as a listen-only Web cast on www.kcsa.com. The Web cast will be archived for 30 days.

Following brief opening remarks, the conference call will be open for a question-and-answer session. The conference call will be available for telephonic replay from February 4, 2003 through February 7, 2003. To access the replay dial 1-877-519-4471 ID replay code: 3716874

About HealthExtras, Inc. (www.healthextras.com)

HealthExtras, Inc., a pharmacy benefit management company, currently provides benefits to over two million members and the Company's clients include managed care organizations, large employer groups, unions, government agencies and individual consumers.

The Company's integrated pharmacy benefit management services include: claims processing, mail order services, benefit design consultation, drug utilization review, formulary management and drug data analysis services. Additionally, the Company operates a national retail pharmacy network with over 53,000 participating pharmacies.

You may register to receive HealthExtras future press releases or to download a complete Digital Investor Kit(TM) including press releases, regulatory filings and corporate materials by clicking on the "KCSA Interactive Platform" icon at www.kcsa.com.

This press release may contain forward-looking information. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. Forward-looking statements may be significantly impacted by certain risks and uncertainties described in HealthExtras' filings with the Securities and Exchange Commission.

--30--KK/ny*